Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Skystar Bio-Pharmaceutical Co (NASDAQ:SKBI)

1.98
Delayed Data
As of Jul 31
 +0.04 / +2.06%
Today’s Change
1.67
Today|||52-Week Range
5.92
-53.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$17.2M

Company Description

Skystar Bio-Pharmaceutical Co. is a holding company that engages in the research, development, production, distribution, and sale of veterinary healthcare and medical care products. It operates through the following product lines: micro-organism, veterinary medicine, feed additives, and bio-pharmaceutical veterinary vaccine. The company was founded in 1997 and is headquartered in Xi'an, China.

Contact Information

Skystar Bio-Pharmaceutical Co.
4/F Building B, Chuangye Square
Xi'an Shaanxi 710000
P:862988193188
Investor Relations:
(629) 645-4433

Employees

Shareholders

Other institutional6.45%
Individual stakeholders33.77%
Mutual fund holders0.49%

Top Executives

Wei Bing LuChairman & Chief Executive Officer
Bing MeiCFO & Principal Accounting Officer
R. Scott CramerNon-Executive Director & IR Contact
Wei WenSecretary & Director